{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:15:10Z","timestamp":1780514110551,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006128","name":"Svenska Frimurarorden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004158","name":"Marcus Wallenbergs Stiftelse f\u00f6r Internationellt Vetenskapligt Samarbete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007464","name":"Torsten S\u00f6derbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007464","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005737","name":"Universit\u00e9 Pierre et Marie Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005737","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation pour la recherche sur Alzheimer"},{"DOI":"10.13039\/501100006072","name":"Commissariat G\u00e9n\u00e9ral \u00e0 l'Investissement","doi-asserted-by":"publisher","award":["ANR-10-IAIHU-06 (HH)"],"award-info":[{"award-number":["ANR-10-IAIHU-06 (HH)"]}],"id":[{"id":"10.13039\/501100006072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13195-017-0313-3","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T18:35:42Z","timestamp":1508783742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Preclinical effects of APOE \u03b54 on cerebrospinal fluid A\u03b242 concentrations"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-1602","authenticated-orcid":false,"given":"Ronald","family":"Lautner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Skillb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"313_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368:387\u2013403.","journal-title":"Lancet"},{"key":"313_CR2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921\u20133.","journal-title":"Science"},{"key":"313_CR3","first-page":"a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"313_CR4","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3:89ra57.","journal-title":"Sci Transl Med"},{"key":"313_CR5","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM. ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110:E1807\u201316.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"313_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6:131\u201344.","journal-title":"Nat Rev Neurol"},{"key":"313_CR7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/brain\/awu367","volume":"138","author":"N Mattsson","year":"2015","unstructured":"Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, Trojanowski JQ, Zetterberg H, Blennow K, Weiner MW. Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease. Brain. 2015;138:772\u201383.","journal-title":"Brain"},{"key":"313_CR8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","volume":"139","author":"S Palmqvist","year":"2016","unstructured":"Palmqvist S, Mattsson N, Hansson O. Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography. Brain. 2016;139:1226\u201336.","journal-title":"Brain"},{"key":"313_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","volume":"36","author":"K Blennow","year":"2015","unstructured":"Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H. Amyloid biomarkers in Alzheimer's disease. Trends Pharmacol Sci. 2015;36:297\u2013309.","journal-title":"Trends Pharmacol Sci"},{"key":"313_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","volume":"55","author":"D Galasko","year":"1998","unstructured":"Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, et al. High cerebrospinal fluid tau and low amyloid \u03b242 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol. 1998;55:937\u201345.","journal-title":"Arch Neurol"},{"key":"313_CR11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","volume":"56","author":"T Sunderland","year":"2004","unstructured":"Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, et al. Cerebrospinal fluid \u03b2-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE \u03b54 allele. Biol Psychiatry. 2004;56:670\u20136.","journal-title":"Biol Psychiatry"},{"key":"313_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009;65:403\u201313.","journal-title":"Ann Neurol"},{"key":"313_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.21953","volume":"67","author":"P Vemuri","year":"2010","unstructured":"Vemuri P, Wiste HJ, Weigand SD, Knopman DS, Shaw LM, Trojanowski JQ, Aisen PS, Weiner M, Petersen RC, Jack Jr CR. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol. 2010;67:308\u201316.","journal-title":"Ann Neurol"},{"key":"313_CR14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamapsychiatry.2014.1060","volume":"71","author":"R Lautner","year":"2014","unstructured":"Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Palsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, et al. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiat. 2014;71:1183\u201391.","journal-title":"JAMA Psychiat"},{"key":"313_CR15","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","volume":"62","author":"JA Prince","year":"2004","unstructured":"Prince JA, Zetterberg H, Andreasen N, Marcusson J, Blennow K. APOE \u03b54 allele is associated with reduced cerebrospinal fluid levels of A\u03b242. Neurology. 2004;62:2116\u20138.","journal-title":"Neurology"},{"key":"313_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JAD-2011-110329","volume":"26","author":"CG Schipke","year":"2011","unstructured":"Schipke CG, Jessen F, Teipel S, Luckhaus C, Wiltfang J, Esselmann H, Frolich L, Maier W, Ruther E, Heppner FL, et al. Long-term stability of Alzheimer's disease biomarker proteins in cerebrospinal fluid. J Alzheimers Dis. 2011;26:255\u201362.","journal-title":"J Alzheimers Dis"},{"key":"313_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2016.05.014","volume":"467","author":"J Kuhlmann","year":"2017","unstructured":"Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, et al. CSF A\u03b21-42\u2014an excellent but complicated Alzheimer's biomarker\u2014a route to standardisation. Clin Chim Acta. 2017;467:27\u201333.","journal-title":"Clin Chim Acta"},{"key":"313_CR18","first-page":"986310","volume":"2010","author":"M Bjerke","year":"2010","unstructured":"Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, Andreasen N, Zetterberg H, Andreasson U, Blennow K. Confounding factors influencing amyloid beta concentration in cerebrospinal fluid. Int J Alzheimers Dis. 2010;2010:986310.","journal-title":"Int J Alzheimers Dis"},{"key":"313_CR19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K. Cerebrospinal fluid \u03b2-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56:673\u201380.","journal-title":"Arch Neurol"},{"key":"313_CR20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K. Simultaneous measurement of \u03b2-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005;51:336\u201345.","journal-title":"Clin Chem"},{"key":"313_CR21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67:122\u201331.","journal-title":"Ann Neurol"},{"key":"313_CR22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jalz.2014.11.002","volume":"11","author":"PS Insel","year":"2015","unstructured":"Insel PS, Mattsson N, Donohue MC, Mackin RS, Aisen PS, Jack Jr CR, Shaw LM, Trojanowski JQ, Weiner MW. The transitional association between \u03b2-amyloid pathology and regional brain atrophy. Alzheimers Dement. 2015;11:1171\u20139.","journal-title":"Alzheimers Dement"},{"key":"313_CR23","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1212\/WNL.0000000000002683","volume":"86","author":"PS Insel","year":"2016","unstructured":"Insel PS, Mattsson N, Mackin RS, Scholl M, Nosheny RL, Tosun D, Donohue MC, Aisen PS, Jagust WJ, Weiner MW. Accelerating rates of cognitive decline and imaging markers associated with \u03b2-amyloid pathology. Neurology. 2016;86:1887\u201396.","journal-title":"Neurology"},{"key":"313_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamaneurol.2014.446","volume":"71","author":"N Mattsson","year":"2014","unstructured":"Mattsson N, Insel PS, Nosheny R, Tosun D, Trojanowski JQ, Shaw LM, Jack Jr CR, Donohue MC, Weiner MW. Emerging \u03b2-amyloid pathology and accelerated cortical atrophy. JAMA Neurol. 2014;71:725\u201334.","journal-title":"JAMA Neurol"},{"key":"313_CR25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamaneurol.2014.4530","volume":"72","author":"N Mattsson","year":"2015","unstructured":"Mattsson N, Insel PS, Donohue M, Jagust W, Sperling R, Aisen P, Weiner MW. Predicting reduction of cerebrospinal fluid \u03b2-amyloid 42 in cognitively healthy controls. JAMA Neurol. 2015;72:554\u201360.","journal-title":"JAMA Neurol"},{"key":"313_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","volume":"361","author":"RJ Caselli","year":"2009","unstructured":"Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, et al. Longitudinal modeling of age-related memory decline and the APOE \u03b54 effect. N Engl J Med. 2009;361:255\u201363.","journal-title":"N Engl J Med"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-017-0313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:22:40Z","timestamp":1719530560000},"score":1,"resource":{"primary":{"URL":"http:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-017-0313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1186\/s13195-017-0313-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"article-number":"87"}}